UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 25, 2008
infoGROUP Inc.
(Exact name of Registrant as specified in its charter)
| |
|
|
|
|
Delaware
(State or other
jurisdiction of
incorporation)
|
|
0-19598
(Commission File Number)
|
|
47-0751545
(IRS Employer
Identification No.) |
| |
|
|
| 5711 South 86th Circle |
|
|
| Omaha, Nebraska
|
|
68127 |
| (Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code: (402) 593-4500
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain Officers
(b) As previous disclosed, on August 20, 2008, the Board of Directors (the “Board”) of infoGROUP
Inc. (the “Company”) entered into a Stipulation of Settlement (the “Stipulation of Settlement”)
with the parties named in the consolidated complaint In re infoUSA, Inc. Shareholders Litigation,
Consol. Civil Action No. 1956-CC (Del. Ch.) (the “Derivative Litigation”).
As part of the Stipulation of Settlement, George F. Haddix and Vasant H. Raval, each a
director of the Company, had agreed to tender their resignations from the Board no later than five
days from the date of the Stipulation of Settlement. On August 25, 2008, Drs. Haddix and Raval
submitted their resignations to the Company. Their resignations are subject to and will become
effective on the date on which the court’s order approving the Stipulation of Settlement (if such
approval occurs) and dismissing with prejudice the Derivative Litigation becomes final.
For more information on the Stipulation of Settlement, please refer to the Company’s Form
8-K/A filed on August 22, 2008 with the Securities and Exchange Commission.